Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 814

1.

Validation and development of the CHAARTED criteria in patients with hormone-naïve metastatic prostate cancer: A multi-institutional retrospective study in Japan.

Okamoto T, Hatakeyama S, Narita S, Arai Y, Habuchi T, Ohyama C.

Int J Urol. 2019 Oct 15. doi: 10.1111/iju.14136. [Epub ahead of print] No abstract available.

PMID:
31617248
2.

Histological evidence for the cardiac safety of high-dose pegylated liposomal doxorubicin in a patient with HIV-associated Kaposi sarcoma: a case report and literature review.

Ishihara A, Hatakeyama S, Suzuki J, Amano Y, Sasahara T, Toshima M, Morisawa Y.

BMC Infect Dis. 2019 Oct 15;19(1):848. doi: 10.1186/s12879-019-4500-7.

3.

Clinical Characterization of Low Prostate-specific Antigen on Prognosis in Patients With Metastatic Castration-naive Prostate Cancer.

Kodama H, Hatakeyama S, Narita S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Narita T, Sato H, Mitsuzuka K, Tochigi T, Tsuchiya N, Arai Y, Habuchi T, Ohyama C.

Clin Genitourin Cancer. 2019 Sep 10. pii: S1558-7673(19)30260-5. doi: 10.1016/j.clgc.2019.05.029. [Epub ahead of print]

PMID:
31575477
4.

The Relationship Between Gait Function and Erectile Dysfunction: Results from a Community-Based Cross-Sectional Study in Japan.

Okamoto T, Hatakeyama S, Imai A, Konishi S, Okita K, Yamamoto H, Tobisawa Y, Yoneyama T, Mori K, Yoneyama T, Hashimoto Y, Nakaji S, Ohyama C.

J Sex Med. 2019 Sep 12. pii: S1743-6095(19)31387-6. doi: 10.1016/j.jsxm.2019.08.018. [Epub ahead of print]

PMID:
31522986
5.

Editorial Comment to Impact of post-void residual urine volume on intravesical recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma.

Hatakeyama S, Ohyama C.

Int J Urol. 2019 Sep 14. doi: 10.1111/iju.14113. [Epub ahead of print] No abstract available.

PMID:
31522463
6.

Multicenter prospective study validating the efficacy of a quantitative assessment tool for frailty in patients with urological cancers.

Soma O, Hatakeyama S, Okamoto T, Fujita N, Hamano I, Tanaka T, Momota M, Yoneyama T, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Saitoh H, Nakaji S, Suzuki T, Ohyama C.

Med Oncol. 2019 Sep 13;36(10):88. doi: 10.1007/s12032-019-1313-x.

PMID:
31520152
7.

Changes in conditional net survival and dynamic prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy.

Narita S, Nomura K, Hatakeyama S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Sato H, Mitsuzuka K, Tochigi T, Tsuchiya N, Ohyama C, Arai Y, Nagashima K, Habuchi T.

Cancer Med. 2019 Sep 11. doi: 10.1002/cam4.2502. [Epub ahead of print]

8.

Autophagy promotes citrullination of VIM (vimentin) and its interaction with major histocompatibility complex class II in synovial fibroblasts.

Sugawara E, Kato M, Kudo Y, Lee W, Hisada R, Fujieda Y, Oku K, Bohgaki T, Amengual O, Yasuda S, Onodera T, Hatakeyama S, Atsumi T.

Autophagy. 2019 Sep 8:1-10. doi: 10.1080/15548627.2019.1664144. [Epub ahead of print]

PMID:
31486697
9.

Seasonal and annual changes in PAH concentrations in a remote site in the Pacific Ocean.

Miura K, Shimada K, Sugiyama T, Sato K, Takami A, Chan CK, Kim IS, Kim YP, Lin NH, Hatakeyama S.

Sci Rep. 2019 Aug 29;9(1):12591. doi: 10.1038/s41598-019-47409-9.

10.

Autocrine activin A signalling in ovarian cancer cells regulates secretion of interleukin 6, autophagy, and cachexia.

Pettersen K, Andersen S, van der Veen A, Nonstad U, Hatakeyama S, Lambert C, Lach-Trifilieff E, Moestue S, Kim J, Grønberg BH, Schilb A, Jacobi C, Bjørkøy G.

J Cachexia Sarcopenia Muscle. 2019 Aug 21. doi: 10.1002/jcsm.12489. [Epub ahead of print]

11.

Prognostic significance of early changes in serum biomarker levels in patients with newly diagnosed metastatic prostate cancer.

Narita S, Nomura K, Hatakeyama S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Sato H, Mitsuzuka K, Tochigi T, Tsuchiya N, Ohyama C, Arai Y, Nagashima K, Habuchi T.

Sci Rep. 2019 Aug 19;9(1):12071. doi: 10.1038/s41598-019-48600-8.

12.

Validation of the IMDC Prognostic Model in Patients With Metastatic Renal-Cell Carcinoma Treated With First-Line Axitinib: A Multicenter Retrospective Study.

Konishi S, Hatakeyama S, Numakura K, Narita S, Inoue T, Saito M, Tokui N, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Narita S, Kawaguchi T, Habuchi T, Ohyama C.

Clin Genitourin Cancer. 2019 Oct;17(5):e1080-e1089. doi: 10.1016/j.clgc.2019.07.006. Epub 2019 Jul 20.

PMID:
31416753
13.

Ankylosing spondylitis presenting with enthesitis at an uncommon site and fever of unknown origin.

Kanda N, Takeda K, Hatakeyama S, Matsumura M.

BMJ Case Rep. 2019 Aug 10;12(8). pii: e230113. doi: 10.1136/bcr-2019-230113.

PMID:
31401572
14.

Bilateral scrotal mass mimicking testicular cancer: An unusual presentation of sarcoidosis.

Konishi S, Hatakeyama S, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C.

Int J Urol. 2019 Aug 4. doi: 10.1111/iju.14089. [Epub ahead of print] No abstract available.

PMID:
31379006
15.

C-reactive protein/albumin ratio is a predictive factor for prognosis in patients with metastatic renal cell carcinoma.

Konishi S, Hatakeyama S, Tanaka T, Ikehata Y, Tanaka T, Hamano I, Fujita N, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Masumori N, Kitamura H, Ohyama C.

Int J Urol. 2019 Oct;26(10):992-998. doi: 10.1111/iju.14078. Epub 2019 Jul 24.

PMID:
31342557
16.

A novel tissue-selective β2-adrenoceptor agonist with minimized cardiovascular effects, 5-HOB, attenuates neuropathic pain in mice.

Jourdain M, Hatakeyama S.

BMC Res Notes. 2019 Jul 15;12(1):413. doi: 10.1186/s13104-019-4466-y.

17.

Painful subcutaneous edema of the lumbar region in IgA vasculitis.

Shimizu A, Shimabukuro M, Shimizu M, Asai S, Tomizawa S, Hatakeyama S, Yamada Y.

Pediatr Int. 2019 Jun;61(6):624-625. doi: 10.1111/ped.13853. No abstract available.

PMID:
31242537
18.

Azithromycin plus β-lactam versus levofloxacin plus β-lactam for severe community-acquired pneumonia: A retrospective nationwide database analysis.

Suzuki J, Sasabuchi Y, Hatakeyama S, Matsui H, Sasahara T, Morisawa Y, Yamada T, Yasunaga H.

J Infect Chemother. 2019 Jun 19. pii: S1341-321X(19)30162-X. doi: 10.1016/j.jiac.2019.05.027. [Epub ahead of print]

PMID:
31227381
19.

Pharmacological profiling of a dual FAK/IGF-1R kinase inhibitor TAE226 in cellular and in vivo tumor models.

Fukami S, Tomioka D, Murakami Y, Honda T, Hatakeyama S.

BMC Res Notes. 2019 Jun 18;12(1):347. doi: 10.1186/s13104-019-4389-7.

20.

Development and Validation of a Novel Prognostic Model for Predicting Overall Survival in Treatment-naïve Castration-sensitive Metastatic Prostate Cancer.

Akamatsu S, Kubota M, Uozumi R, Narita S, Takahashi M, Mitsuzuka K, Hatakeyama S, Sakurai T, Kawamura S, Ishidoya S, Hoshi S, Ishida M, Mizuno K, Ogura K, Goto T, Terada N, Kobayashi T, Yamasaki T, Inoue T, Tsuchiya N, Ohyama C, Arai Y, Habuchi T, Morita S, Ogawa O.

Eur Urol Oncol. 2019 May;2(3):320-328. doi: 10.1016/j.euo.2018.10.011. Epub 2018 Nov 23.

PMID:
31200847
21.

Clinical significance of the LacdiNAc-glycosylated prostate-specific antigen assay for prostate cancer detection.

Yoneyama T, Tobisawa Y, Kaneko T, Kaya T, Hatakeyama S, Mori K, Sutoh Yoneyama M, Okubo T, Mitsuzuka K, Duivenvoorden W, Pinthus JH, Hashimoto Y, Ito A, Koie T, Suda Y, Gardiner RA, Ohyama C.

Cancer Sci. 2019 Aug;110(8):2573-2589. doi: 10.1111/cas.14082. Epub 2019 Jun 27.

22.

Editorial Comment.

Hatakeyama S, Imai A, Ohyama C.

J Urol. 2019 Aug;202(2):359-360. doi: 10.1097/01.JU.0000559824.07845.4c. Epub 2019 Jul 8. No abstract available.

PMID:
31095466
23.

Development of an MSI-positive colon tumor with aberrant DNA methylation in a PPAP patient.

Yamaguchi K, Shimizu E, Yamaguchi R, Imoto S, Komura M, Hatakeyama S, Noguchi R, Takane K, Ikenoue T, Gohda Y, Yano H, Miyano S, Furukawa Y.

J Hum Genet. 2019 Aug;64(8):729-740. doi: 10.1038/s10038-019-0611-7. Epub 2019 May 14.

PMID:
31089268
24.

Histoplasmosis among HIV-Infected Patients in Japan: a Case Report and Literature Review.

Hatakeyama S, Okamoto K, Ogura K, Sugita C, Nagi M.

Jpn J Infect Dis. 2019 Sep 19;72(5):330-333. doi: 10.7883/yoken.JJID.2018.354. Epub 2019 Apr 26.

25.

Antibiotic prescription among outpatients in a prefecture of Japan, 2012-2013: a retrospective claims database study.

Hashimoto H, Matsui H, Sasabuchi Y, Yasunaga H, Kotani K, Nagai R, Hatakeyama S.

BMJ Open. 2019 Apr 3;9(4):e026251. doi: 10.1136/bmjopen-2018-026251.

26.

Evaluation of therapeutic effects of FAK inhibition in murine models of atherosclerosis.

Yamaura T, Kasaoka T, Iijima N, Kimura M, Hatakeyama S.

BMC Res Notes. 2019 Apr 2;12(1):200. doi: 10.1186/s13104-019-4220-5.

27.

Total Synthesis of Lajollamycin B.

Nishimaru T, Eto K, Komine K, Ishihara J, Hatakeyama S.

Chemistry. 2019 Jun 12;25(33):7927-7934. doi: 10.1002/chem.201901069. Epub 2019 May 15.

PMID:
30924208
28.

Clinical Characteristics of Saffold Virus Infection in Children.

Ugai S, Iwaya A, Taneichi H, Hirokawa C, Aizawa Y, Hatakeyama S, Saitoh A.

Pediatr Infect Dis J. 2019 Aug;38(8):781-785. doi: 10.1097/INF.0000000000002298.

PMID:
30908431
29.

Significance of repeat magnetic resonance imaging in diagnosing vertebral osteomyelitis.

Kamiya N, Hatakeyama S, Kanda N, Yonaha S, Akine D, Yamamoto Y, Matsumura M.

J Gen Fam Med. 2018 Dec 20;20(2):68-71. doi: 10.1002/jgf2.226. eCollection 2019 Mar.

30.

Pharmacological Characterization of a Novel 5-Hydroxybenzothiazolone-Derived β 2-Adrenoceptor Agonist with Functional Selectivity for Anabolic Effects on Skeletal Muscle Resulting in a Wider Cardiovascular Safety Window in Preclinical Studies.

Koziczak-Holbro M, Rigel DF, Dumotier B, Sykes DA, Tsao J, Nguyen NH, Bösch J, Jourdain M, Flotte L, Adachi Y, Kiffe M, Azria M, Fairhurst RA, Charlton SJ, Richardson BP, Lach-Trifilieff E, Glass DJ, Ullrich T, Hatakeyama S.

J Pharmacol Exp Ther. 2019 May;369(2):188-199. doi: 10.1124/jpet.118.255307. Epub 2019 Feb 28.

PMID:
30819762
31.

Impact of distance between donor and recipient hospitals on cadaveric kidney transplantation outcomes.

Hamano I, Hatakeyama S, Yamamoto H, Fujita T, Murakami R, Shimada M, Imai A, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Narumi S, Saitoh H, Suzuki T, Tomita H, Ohyama C.

Clin Exp Nephrol. 2019 Jun;23(6):807-813. doi: 10.1007/s10157-019-01710-z. Epub 2019 Feb 27.

PMID:
30809748
32.

Impact of Disagreement Between Two Risk Group Models on Prognosis in Patients With Metastatic Renal-Cell Carcinoma.

Okita K, Hatakeyama S, Tanaka T, Ikehata Y, Tanaka T, Fujita N, Ishibashi Y, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Masumori N, Kitamura H, Ohyama C.

Clin Genitourin Cancer. 2019 Jun;17(3):e440-e446. doi: 10.1016/j.clgc.2019.01.006. Epub 2019 Jan 17.

PMID:
30772204
33.

Impact of nadir PSA level and time to nadir during initial androgen deprivation therapy on prognosis in patients with metastatic castration-resistant prostate cancer.

Hamano I, Hatakeyama S, Narita S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Sato H, Mitsuzuka K, Tochigi T, Tsuchiya N, Arai Y, Habuchi T, Ohyama C.

World J Urol. 2019 Feb 7. doi: 10.1007/s00345-019-02664-3. [Epub ahead of print]

PMID:
30729312
34.

Evaluating the effects of switching from dutasteride to tadalafil in benign prostatic hyperplasia patients with lower urinary tract symptoms: A randomized, open-label, multicenter study.

Matsumoto T, Hatakeyama S, Narita T, Yoneyama T, Hashimoto Y, Ohyama C.

Int J Urol. 2019 Apr;26(4):522-523. doi: 10.1111/iju.13908. Epub 2019 Jan 18. No abstract available.

PMID:
30659664
35.

A cut-off value of shear wave speed to distinguish nonalcoholic steatohepatitis candidates.

Suda T, Kanefuji T, Abe A, Nagayama I, Hoshi T, Morita S, Yagi K, Hatakeyama S, Hayatsu M, Hasegawa N, Terai S.

Medicine (Baltimore). 2019 Jan;98(2):e13958. doi: 10.1097/MD.0000000000013958.

36.

Impact of nutritional status on the prognosis of patients with metastatic hormone-naïve prostate cancer: a multicenter retrospective cohort study in Japan.

Okamoto T, Hatakeyama S, Narita S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Sato H, Mitsuzuka K, Tochigi T, Tsuchiya N, Arai Y, Habuchi T, Ohyama C.

World J Urol. 2019 Sep;37(9):1827-1835. doi: 10.1007/s00345-018-2590-2. Epub 2018 Dec 4.

PMID:
30511214
37.

Postoperative weight loss followed by radical cystectomy predicts poor prognosis in patients with muscle-invasive bladder cancer.

Okita K, Hatakeyama S, Fujita N, Konishi S, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Ito H, Yoshikawa K, Koie T, Ohyama C.

Med Oncol. 2018 Nov 26;36(1):7. doi: 10.1007/s12032-018-1232-2.

PMID:
30478763
38.

Comparison of axitinib and sunitinib as first-line therapies for metastatic renal cell carcinoma: a real-world multicenter analysis.

Konishi S, Hatakeyama S, Tanaka T, Ikehata Y, Tanaka T, Fujita N, Ishibashi Y, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Masumori N, Kitamura H, Ohyama C.

Med Oncol. 2018 Nov 24;36(1):6. doi: 10.1007/s12032-018-1231-3.

PMID:
30474747
39.

Clinical impact of glomerular basement membrane thickness on post-donation renal function in living donors.

Kubota Y, Hatakeyama S, Narita I, Shimada M, Hashimoto Y, Ohyama C.

Int J Urol. 2019 Feb;26(2):309-311. doi: 10.1111/iju.13850. Epub 2018 Nov 14. No abstract available.

PMID:
30430663
40.

Loss of TRIM29 Alters Keratin Distribution to Promote Cell Invasion in Squamous Cell Carcinoma.

Yanagi T, Watanabe M, Hata H, Kitamura S, Imafuku K, Yanagi H, Homma A, Wang L, Takahashi H, Shimizu H, Hatakeyama S.

Cancer Res. 2018 Dec 15;78(24):6795-6806. doi: 10.1158/0008-5472.CAN-18-1495. Epub 2018 Nov 2.

PMID:
30389700
41.

Brain-Derived Neurotrophic Factor Improves Limited Exercise Capacity in Mice With Heart Failure.

Matsumoto J, Takada S, Kinugawa S, Furihata T, Nambu H, Kakutani N, Tsuda M, Fukushima A, Yokota T, Tanaka S, Takahashi H, Watanabe M, Hatakeyama S, Matsumoto M, Nakayama KI, Otsuka Y, Sabe H, Tsutsui H, Anzai T.

Circulation. 2018 Oct 30;138(18):2064-2066. doi: 10.1161/CIRCULATIONAHA.118.035212. No abstract available.

PMID:
30372141
42.

Synthetic Studies on Spirolides A and B: Formation of the Upper Carbon Framework Based on a Lewis Acid Template-Catalyzed Diels-Alder Reaction.

Ishihara J, Usui F, Kurose T, Baba T, Kawaguchi Y, Watanabe Y, Hatakeyama S.

Chemistry. 2019 Jan 28;25(6):1543-1552. doi: 10.1002/chem.201804977. Epub 2018 Dec 20.

PMID:
30357942
43.

Whole-body vibration training improves the balance ability and leg strength of athletic throwers.

Takanashi Y, Chinen Y, Hatakeyama S.

J Sports Med Phys Fitness. 2019 Jul;59(7):1110-1118. doi: 10.23736/S0022-4707.18.09012-6. Epub 2018 Oct 10.

PMID:
30317837
44.

Condyloma Acuminata of the Urethra in a Male Renal Transplant Recipient: A Case Report.

Hamano I, Hatakeyama S, Yamamoto H, Fujita T, Murakami R, Shimada M, Imai A, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Narumi S, Saitoh H, Suzuki T, Tomita H, Ohyama C.

Transplant Proc. 2018 Oct;50(8):2553-2557. doi: 10.1016/j.transproceed.2018.02.182. Epub 2018 Mar 20.

PMID:
30316397
45.

LET dependence on killing effect and mutagenicity in the model filamentous fungus Neurospora crassa.

Ma L, Kazama Y, Hirano T, Morita R, Tanaka S, Abe T, Hatakeyama S.

Int J Radiat Biol. 2018 Dec;94(12):1125-1133. doi: 10.1080/09553002.2019.1524940. Epub 2018 Oct 11.

PMID:
30307372
46.

Tuberculous Peritonitis.

Okamoto K, Hatakeyama S.

N Engl J Med. 2018 Sep 20;379(12):e20. doi: 10.1056/NEJMicm1713168. No abstract available.

47.

Neoadjuvant chemohormonal therapy followed by robot-assisted and minimum incision endoscopic radical prostatectomy in patients with high-risk prostate cancer: comparison of perioperative and oncological outcomes at single institution.

Fujita N, Koie T, Hashimoto Y, Narita T, Tobisawa Y, Tanaka T, Noro D, Oikawa M, Hagiwara K, Yoneyama T, Imai A, Yamamoto H, Hatakeyama S, Yoneyama T, Ohyama C.

Int Urol Nephrol. 2018 Nov;50(11):1999-2005. doi: 10.1007/s11255-018-1985-8. Epub 2018 Sep 18.

PMID:
30229466
48.

Relationship between oxidative stress and lower urinary tract symptoms: results from a community health survey in Japan.

Matsumoto T, Hatakeyama S, Imai A, Tanaka T, Hagiwara K, Konishi S, Okita K, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Nakaji S, Ohyama C.

BJU Int. 2019 May;123(5):877-884. doi: 10.1111/bju.14535. Epub 2018 Oct 15.

PMID:
30216623
49.

Robotic cross-folded U-configuration intracorporeal ileal neobladder for muscle-invasive bladder cancer: Initial experience and functional outcomes.

Koie T, Ohyama C, Yoneyama T, Nagasaka H, Yamamoto H, Imai A, Hatakeyama S, Hashimoto Y.

Int J Med Robot. 2018 Dec;14(6):e1955. doi: 10.1002/rcs.1955. Epub 2018 Sep 14.

50.

Low serum butyrylcholinesterase is independently related to low fetuin-A in patients on hemodialysis: a cross-sectional study.

Okamoto T, Tsutaya C, Hatakeyama S, Konishi S, Okita K, Tanaka Y, Imanishi K, Takashima T, Saitoh F, Suzuki T, Ohyama C.

Int Urol Nephrol. 2018 Sep;50(9):1713-1720. doi: 10.1007/s11255-018-1957-z. Epub 2018 Aug 20.

PMID:
30128921

Supplemental Content

Loading ...
Support Center